Extranodal diffuse large B cell lymphoma: molecular features, prognosis, and risk of central nervous system recurrence
TA Ollila, AJ Olszewski - Current treatment options in oncology, 2018 - Springer
Opinion statement Diffuse large B cell lymphoma (DLBCL) arises from extranodal organs in
about 30% of cases. Its prognosis and risk of recurrence in the central nervous system …
about 30% of cases. Its prognosis and risk of recurrence in the central nervous system …
Thyroid autoimmune disorders and cancer
SM Ferrari, P Fallahi, G Elia, F Ragusa, I Ruffilli… - Seminars in cancer …, 2020 - Elsevier
In the last decades, many studies conducted in vitro, and in vivo, have shown that thyroid
autoimmunity and thyroid cancer (TC)(mainly papillary TC) can be concomitant, even if the …
autoimmunity and thyroid cancer (TC)(mainly papillary TC) can be concomitant, even if the …
[PDF][PDF] Guidelines for the management of thyroid cancer.
P Perros, K Boelaert, S Colley, C Evans… - Clinical …, 2014 - thyroidcancercanada.org
BTA_Guidelines_for_the_Management_of_Thyroid Cancer_E Page 1 CLINICAL
ENDOCRINOLOGY VOLUME 81 SUPPLEMENT 1 JULY 2014 THE CLINICAL JOURNAL OF …
ENDOCRINOLOGY VOLUME 81 SUPPLEMENT 1 JULY 2014 THE CLINICAL JOURNAL OF …
Lymphoma development in patients with autoimmune and inflammatory disorders–what are the driving forces?
E Baecklund, KE Smedby, LA Sutton, J Askling… - Seminars in cancer …, 2014 - Elsevier
For decades, it has been known that patients with certain autoimmune and inflammatory
disorders, such as rheumatoid arthritis (RA) and primary Sjögren's syndrome (pSS), have an …
disorders, such as rheumatoid arthritis (RA) and primary Sjögren's syndrome (pSS), have an …
Sunitinib in the treatment of thyroid cancer
SM Ferrari, M Centanni, C Virili… - Current medicinal …, 2019 - ingentaconnect.com
Background: Sunitinib (SU11248) is an oral multi-target tyrosine kinase inhibitor (TKI) with
low molecular weight, that inhibits platelet-derived growth factor receptors (PDGF-Rs) and …
low molecular weight, that inhibits platelet-derived growth factor receptors (PDGF-Rs) and …
A review of primary thyroid lymphoma: molecular factors, diagnosis and management
ET Pavlidis, TE Pavlidis - Journal of Investigative Surgery, 2019 - Taylor & Francis
Purpose/aim: To focus on current aspects of primary thyroid lymphoma (PTL), which is a rare
clinical entity usually manifested by a rapidly growing mass in the neck that can cause …
clinical entity usually manifested by a rapidly growing mass in the neck that can cause …
[HTML][HTML] Primary extranodal B-cell lymphoma: current concepts and treatment strategies
B Vannata, E Zucca - Chinese clinical oncology, 2015 - cco.amegroups.org
Around 30% of all non-Hodgkin lymphoma (NHL) cases arise from extranodal sites. Often
the primary extranodal presentation requires site-specific strategies either for diagnosis or …
the primary extranodal presentation requires site-specific strategies either for diagnosis or …
[HTML][HTML] Primary thyroid lymphoma: A single-center experience
JS Lee, SJ Shin, HJ Yun, SM Kim, H Chang… - Frontiers in …, 2023 - frontiersin.org
Background Primary thyroid lymphoma (PTL) is a very rare entity accounting for 5% of all
thyroid malignancies and less than 2% of lymphomas. PTLs are classified as non-Hodgkin's …
thyroid malignancies and less than 2% of lymphomas. PTLs are classified as non-Hodgkin's …
Clinical presentation and diagnostic challenges of thyroid lymphoma: a cohort study
A Sharma, S Jasim, CC Reading, KM Ristow… - Thyroid, 2016 - liebertpub.com
Background: Thyroid lymphoma is a relatively rare disease often posing a diagnostic
challenge. Reaching the final diagnosis can be delayed if insufficient biopsy material is …
challenge. Reaching the final diagnosis can be delayed if insufficient biopsy material is …
[HTML][HTML] Effectiveness of core needle biopsy in the diagnosis of thyroid lymphoma and anaplastic thyroid carcinoma: A systematic review and meta-analysis
V Vander Poorten, N Goedseels… - Frontiers in …, 2022 - frontiersin.org
Background Both anaplastic thyroid carcinoma (ATC) and thyroid lymphoma (TL) clinically
present as rapidly enlarging neck masses. Unfortunately, in this situation, like in any other …
present as rapidly enlarging neck masses. Unfortunately, in this situation, like in any other …